Attendees and participants together hailed the first major meeting dedicated to MRgFUS a success which advances the field significantly 

The comprehensive program of MRgFUS 2008 demonstrated the huge potential of this technology, and illustrates clearly its potential to be the next major therapeutic advance to gain widespread use. This symposium was the first major dedicated meeting for this sector, attracting nearly 350 registrations from 19 countries, with over 50 high quality presentations and panel discussions. Many of these will be available online shortly, please see below for more details. 

Many attendees expressed their excitement after learning of the future role that MRgFUS can plan in the treatment of different cancers, stroke and uterine fibroids during a program which covered the current and future applications of MRgFUS. 

The large number of physicians attending the meeting was welcomed by organizers as a clear indication that MRgFUS is moving towards acceptance in the mainstream of medicine. Nearly half of the attendees were M.D.s in specialties including radiology, radiation oncology, and surgical specialties such as prostate, breast, brain and gynecology. 

The meeting also attracted a large number of scientists, medical physicists, industry researchers, and engineers.  Organizations such as FDA and NIH were well represented in the audience, as were a number of philanthropists, patient support organizations, vendors, and experts in the regulatory and reimbursement fields. 

 

Our thanks to all who attended MRgFUS Symposium 2008 and made it such a great success!

Information on the upcoming MRgFUS 2010 event will be available soon!